Close
Nordic 9Nordic 9

Ginkgo Bioworks (investor - Corporate Investor)

United States
See something wrong or missing? Let us know
Offices:Boston

Ginkgo Bioworks is an American biotech company founded by Tom Knight in Boston.

Average round investment:7.45M USD
Average number per year:2.0
Distribution: 2025 (2)
Portfolio companies: Denmark Octarine Bio
Mostly invests in: Denmark Denmark (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ginkgo Bioworks

Name Criteria
Sweden Hede Capital Partners
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Fashion, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Denmark Noon Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Sweden Impilo
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Denmark MK Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Denmark Thomas Ryge Mikkelsen
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Fashion, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Germany Trumpf Venture
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United Kingdom We Are Human
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Denmark Klaus Nyengaard
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Fashion, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Sweden Karolinska Development
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Denmark Per Falholt
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Fashion, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top